financetom
Business
financetom
/
Business
/
Amundi to get 26% stake in Victory in exchange for US business
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Amundi to get 26% stake in Victory in exchange for US business
Apr 16, 2024 12:41 AM

PARIS, April 16 (Reuters) - Amundi, Europe's

largest asset manager, said on Tuesday it had agreed to sell its

U.S. business to Victory Capital ( VCTR ) in exchange for a 26% stake in

the U.S. company.

The move, aimed at boosting Amundi's access to the world's

biggest financial market, will allow the French asset manager's

clients to access a larger pool of products.

In exchange, Victory Capital ( VCTR ) will be able to serve a

greater number of clients inside and outside its home country,

as the deal involves 15-year reciprocal distribution agreements.

Amundi, which did not disclose the implied value of Victory

Capital's ( VCTR ) equity generated from the transaction, said the deal

involved no cash payment.

As a new reference shareholder of Victory Capital ( VCTR ), Amundi

will have representatives on the board of the U.S. asset

manager, it said.

"The proposed transaction with Victory Capital ( VCTR ) is a unique

opportunity to strengthen our presence in the U.S., while

becoming a strategic shareholder in a reputable U.S.-based asset

management firm with an excellent track record of growth," said

Amundi CEO Valerie Baudson.

Victory Capital ( VCTR ), whose history traces back to 1894, has a

market capitalisation of around $2.7 billion and has $170

billion in total assets under management. Amundi, which is

controlled by French bank Credit Agricole SA, has more than $2

trillion of assets under management.

The reciprocal distribution agreements between the two

companies will allow Amundi to offer Victory Capital's ( VCTR ) products

outside the United States, while Victory Capital ( VCTR ) will offer

Amundi's non-U.S. made products in America.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Garmin Insider Sold Shares Worth $366,277, According to a Recent SEC Filing
Garmin Insider Sold Shares Worth $366,277, According to a Recent SEC Filing
Dec 23, 2024
05:32 PM EST, 12/23/2024 (MT Newswires) -- Douglas G. Boessen, CFO and Treasurer, on December 20, 2024, sold 1,761 shares in Garmin ( GRMN ) for $366,277. Following the Form 4 filing with the SEC, Boessen has control over a total of 27,612 shares of the company, with 27,612 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1121788/000095017024139723/xslF345X05/ownership.xml ...
Ccc Intelligent Solutions Holdings Insider Bought Shares Worth $1,216,240, According to a Recent SEC Filing
Ccc Intelligent Solutions Holdings Insider Bought Shares Worth $1,216,240, According to a Recent SEC Filing
Dec 23, 2024
05:32 PM EST, 12/23/2024 (MT Newswires) -- Neil E. De Crescenzo, Director, on December 20, 2024, executed a purchase for 100,000 shares in Ccc Intelligent Solutions Holdings ( CCCS ) for $1,216,240. Following the Form 4 filing with the SEC, De Crescenzo has control over a total of 100,000 shares of the company, with 100,000 shares held directly. SEC Filing:...
Indaptus Therapeutics Plans 1.94 Million Secondary Share Offering
Indaptus Therapeutics Plans 1.94 Million Secondary Share Offering
Dec 23, 2024
05:42 PM EST, 12/23/2024 (MT Newswires) -- Indaptus Therapeutics ( INDP ) filed a registration statement Monday with the Securities and Exchange Commission for a proposed secondary offering of about 1.94 million shares. The company won't receive any proceeds from the planned offering by selling stockholders. Shares of the company rose 4.6% in after-hours activity. Price: 0.9299, Change: +0.04, Percent...
Cidara Therapeutics Files Secondary Stock Sale Statement
Cidara Therapeutics Files Secondary Stock Sale Statement
Dec 23, 2024
05:31 PM EST, 12/23/2024 (MT Newswires) -- Cidara Therapeutics ( CDTX ) filed a registration statement Monday with the US Securities and Exchange Commission covering the potential resale of up to 7.04 million common shares by certain stockholders from time to time. The company said that 3.89 million of the shares are issued and outstanding, while the remaining are issuable...
Copyright 2023-2026 - www.financetom.com All Rights Reserved